{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:03:50Z","timestamp":1792605830367,"version":"4.5.0"},"reference-count":73,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n In a porcine model of liver transplant, a combined drug approach that targeted the donor graft and graft recipient reduced ischemia-reperfusion injury, a major hurdle to the success of liver transplant.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To assess the effect of a clinical form of a perioperative combined drug approach delivered immediately before implantation to the procured liver and to the liver recipient on the degree of ischemia-reperfusion injury.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This unicentric, investigator-driven, open-label randomized clinical trial with 2 parallel arms was conducted in Belgium from September 2013 through February 2018, with 1-year follow-up. Adults wait-listed for a first solitary full-size liver transplant were screened for eligibility. Exclusion criteria were acute liver failure, kidney failure, contraindication to treatment, participation in another trial, refusal, technical issues, and death while awaiting transplant. Included patients were enrolled and randomized at the time of liver offer. Data were analyzed from May 20, 2019, to May 27, 2020.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n Participants were randomized to a combined drug approach with standard of care (static cold storage) or standard of care only (control group). In the combined drug approach group, following static cold preservation, donor livers were infused with epoprostenol (ex situ, portal vein); recipients were given oral \u03b1-tocopherol and melatonin prior to anesthesia and intravenous antithrombin III, infliximab, apotransferrin, recombinant erythropoietin-\u03b2, C1-inhibitor, and glutathione during the anhepatic and reperfusion phase.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was the posttransplant peak serum aspartate aminotransferase (AST) level within the first 72 hours. Secondary end points were the frequencies of postreperfusion syndrome, ischemia-reperfusion injury score, early allograft dysfunction, surgical complications, ischemic cholangiopathy, acute kidney injury, acute cellular rejection, and graft and patient survival.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Of 93 randomized patients, 21 were excluded, resulting in 72 patients (36 per study arm) in the per protocol analysis (median recipient age, 60 years [IQR, 51.7-66.2 years]; 52 [72.2%] men). Peak AST serum levels were not different in the combined drug approach and control groups (geometric mean, 1262.9 U\/L [95% CI, 946.3-1685.4 U\/L] vs 1451.2 U\/L [95% CI, 1087.4-1936.7 U\/L]; geometric mean ratio, 0.87 [95% CI, 0.58-1.31];\n P<\/jats:italic>\n \u2009=\u2009.49) (to convert AST to \u03bckat\/L, multiply by 0.0167). There also were no significant differences in the secondary end points between the groups.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this randomized clinical trial, the combined drug approach targeting the post\u2013cold storage graft and the recipient did not decrease ischemic-reperfusion injury. The findings suggest that in addition to a downstream strategy that targets the preimplantation liver graft and the graft recipient, a clinically effective combined drug approach may need to include an upstream strategy that targets the donor graft during preservation. Dynamic preservation strategies may provide an appropriate delivery platform.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifier:\n NCT02251041<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.0819","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T11:02:04Z","timestamp":1677582124000},"page":"e230819","source":"Crossref","is-referenced-by-count":18,"title":["Effect of a Combined Drug Approach on the Severity of Ischemia-Reperfusion Injury During Liver Transplant"],"prefix":"10.1001","volume":"6","author":[{"given":"Nicolas","family":"Meurisse","sequence":"first","affiliation":[{"name":"Laboratory of Abdominal Transplantation, Transplantation Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium"},{"name":"Department of Abdominal Transplant Surgery and Transplant Coordination, University Hospitals Leuven, Leuven, Belgium"},{"name":"Department of Abdominal Surgery and Transplantation, CHU de Li\u00e8ge, University of Li\u00e8ge, Li\u00e8ge, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markoen","family":"Mertens","sequence":"additional","affiliation":[{"name":"Laboratory of Abdominal Transplantation, Transplantation Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium"},{"name":"Department of Abdominal Transplant Surgery and Transplant Coordination, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Fieuws","sequence":"additional","affiliation":[{"name":"Laboratory of Abdominal Transplantation, Transplantation Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium"},{"name":"Department of Abdominal Transplant Surgery and Transplant Coordination, University Hospitals Leuven, Leuven, Belgium"},{"name":"Interuniversity Institute for Biostatistics and Statistical Bioinformatics, KU Leuven\u2014University of Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Gilbo","sequence":"additional","affiliation":[{"name":"Laboratory of Abdominal Transplantation, Transplantation Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium"},{"name":"Department of Abdominal Transplant Surgery and Transplant Coordination, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Jochmans","sequence":"additional","affiliation":[{"name":"Laboratory of Abdominal Transplantation, Transplantation Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium"},{"name":"Department of Abdominal Transplant Surgery and Transplant Coordination, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Pirenne","sequence":"additional","affiliation":[{"name":"Laboratory of Abdominal Transplantation, Transplantation Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium"},{"name":"Department of Abdominal Transplant Surgery and Transplant Coordination, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diethard","family":"Monbaliu","sequence":"additional","affiliation":[{"name":"Laboratory of Abdominal Transplantation, Transplantation Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium"},{"name":"Department of Abdominal Transplant Surgery and Transplant Coordination, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"issue":"23","key":"zoi230053r2","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1001\/jama.2015.5328","article-title":"A potential solution to the shortage of solid organs for transplantation.","volume":"313","author":"Wall","year":"2015","journal-title":"JAMA"},{"issue":"5","key":"zoi230053r3","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/liv.2019.39.issue-5","article-title":"Ischaemia reperfusion injury in liver transplantation: cellular and molecular mechanisms.","volume":"39","author":"Dar","year":"2019","journal-title":"Liver Int"},{"issue":"4","key":"zoi230053r4","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/00007890-200208270-00015","article-title":"Influence of marginal donors on liver preservation injury.","volume":"74","author":"Brice\u00f1o","year":"2002","journal-title":"Transplantation"},{"issue":"2","key":"zoi230053r5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrgastro.2012.225","article-title":"Ischaemia-reperfusion injury in liver transplantation\u2014from bench to bedside.","volume":"10","author":"Zhai","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"zoi230053r6","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3390\/cells8101131","article-title":"Inflammasome-mediated inflammation in liver ischemia-reperfusion injury.","volume":"8","author":"Jim\u00e9nez-Castro","year":"2019","journal-title":"Cells"},{"issue":"11","key":"zoi230053r7","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/nm.2507","article-title":"Ischemia and reperfusion\u2014from mechanism to translation.","volume":"17","author":"Eltzschig","year":"2011","journal-title":"Nat Med"},{"issue":"2","key":"zoi230053r8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.cmet.2015.12.009","article-title":"A unifying mechanism for mitochondrial superoxide production during ischemia-reperfusion injury.","volume":"23","author":"Chouchani","year":"2016","journal-title":"Cell Metab"},{"issue":"2","key":"zoi230053r9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/(ISSN)1527-6473","article-title":"Primary graft nonfunction and Kupffer cell activation after liver transplantation from non-heart-beating donors in pigs.","volume":"13","author":"Monbaliu","year":"2007","journal-title":"Liver Transpl"},{"issue":"5","key":"zoi230053r10","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1097\/SLA.0b013e3181bdd787","article-title":"Multifactorial biological modulation of warm ischemia reperfusion injury in liver transplantation from non-heart-beating donors eliminates primary nonfunction and reduces bile salt toxicity.","volume":"250","author":"Monbaliu","year":"2009","journal-title":"Ann Surg"},{"issue":"5","key":"zoi230053r11","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1161\/CIRCRESAHA.115.306569","article-title":"Moving forwards by blocking back-flow: the yin and yang of MI therapy.","volume":"118","author":"Pell","year":"2016","journal-title":"Circ Res"},{"issue":"4 pt B","key":"zoi230053r12","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.bbadis.2017.06.013","article-title":"Post-transplant cholangiopathy: classification, pathogenesis, and preventive strategies.","volume":"1864","author":"de Vries","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"zoi230053r13","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/906965","article-title":"Global consequences of liver ischemia\/reperfusion injury.","volume":"2014","author":"Nastos","year":"2014","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"zoi230053r14","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/lt.24728","article-title":"Hepatic ischemia\/reperfusion injury associates with acute kidney injury in liver transplantation: prospective cohort study.","volume":"23","author":"Jochmans","year":"2017","journal-title":"Liver Transpl"},{"issue":"8","key":"zoi230053r15","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1111\/j.1600-6143.2011.03579.x","article-title":"Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation.","volume":"11","author":"Zhai","year":"2011","journal-title":"Am J Transplant"},{"issue":"20","key":"zoi230053r16","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.3390\/ijms20205034","article-title":"Ischemia\/reperfusion injury revisited: an overview of the latest pharmacological strategies.","volume":"20","author":"Soares","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"2","key":"zoi230053r17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086053","article-title":"A randomized clinical trial testing the anti-inflammatory effects of preemptive inhaled nitric oxide in human liver transplantation.","volume":"9","author":"Lang","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"zoi230053r18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/lt.23527","article-title":"Use of N-acetylcysteine during liver procurement: a prospective randomized controlled study.","volume":"19","author":"D\u2019Amico","year":"2013","journal-title":"Liver Transpl"},{"issue":"4","key":"zoi230053r19","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/j.1600-6143.2011.03441.x","article-title":"rPSGL-Ig for improvement of early liver allograft function: a double-blind, placebo-controlled, single-center phase II study.","volume":"11","author":"Busuttil","year":"2011","journal-title":"Am J Transplant"},{"issue":"2","key":"zoi230053r20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/MOT.0b013e3283373ced","article-title":"Biological modulation of liver ischemia-reperfusion injury.","volume":"15","author":"de Rougemont","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"issue":"1","key":"zoi230053r21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00395-017-0662-x","article-title":"The RISK pathway and beyond.","volume":"113","author":"Rossello","year":"2017","journal-title":"Basic Res Cardiol"},{"issue":"2","key":"zoi230053r22","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/lt.22446","article-title":"Improving the function of liver grafts exposed to warm ischemia by the Leuven drug protocol: exploring the molecular basis by microarray.","volume":"18","author":"Vekemans","year":"2012","journal-title":"Liver Transpl"},{"key":"zoi230053r23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053"},{"issue":"9","key":"zoi230053r24","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1016\/j.transproceed.2014.09.169","article-title":"Belgian modified classification of Maastricht for donors after circulatory death.","volume":"46","author":"Evrard","year":"2014","journal-title":"Transplant Proc"},{"issue":"7","key":"zoi230053r25","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s00268-002-6271-2","article-title":"Intramuscular administration of very high dose of alpha-tocopherol protects liver from severe ischemia\/reperfusion injury.","volume":"26","author":"Giakoustidis","year":"2002","journal-title":"World J Surg"},{"issue":"6","key":"zoi230053r26","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.clnu.2004.05.003","article-title":"Pilot study on the effect of parenteral vitamin E on ischemia and reperfusion induced liver injury: a double blind, randomized, placebo-controlled trial.","volume":"23","author":"Bartels","year":"2004","journal-title":"Clin Nutr"},{"issue":"2","key":"zoi230053r27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00423-010-0668-4","article-title":"Multidrug donor preconditioning prevents cold liver preservation and reperfusion injury.","volume":"396","author":"Moussavian","year":"2011","journal-title":"Langenbecks Arch Surg"},{"issue":"2","key":"zoi230053r28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-079X.2010.00831.x","article-title":"Melatonin protects steatotic and nonsteatotic liver grafts against cold ischemia and reperfusion injury.","volume":"50","author":"Zaoual\u00ed","year":"2011","journal-title":"J Pineal Res"},{"issue":"4","key":"zoi230053r29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/jpi.2005.38.issue-4","article-title":"Exogenous melatonin enhances bile flow and ATP levels after cold storage and reperfusion in rat liver: implications for liver transplantation.","volume":"38","author":"Vairetti","year":"2005","journal-title":"J Pineal Res"},{"issue":"8","key":"zoi230053r30","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/00007890-199410270-00002","article-title":"Hepatoprotection by a PGI2 analogue in complete warm ischemia of the pig liver: prostanoid release from the reperfused liver.","volume":"58","author":"Kim","year":"1994","journal-title":"Transplantation"},{"issue":"11","key":"zoi230053r31","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1007\/BF02385788","article-title":"Efficacy of prostaglandin I2 analog on liver grafts subjected to 30 minutes of warm ischemia.","volume":"27","author":"Kishida","year":"1997","journal-title":"Surg Today"},{"issue":"8","key":"zoi230053r32","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1097\/00007890-199904270-00007","article-title":"Preconditioning of donor livers with prostaglandin I2 before retrieval decreases hepatocellular ischemia-reperfusion injury.","volume":"67","author":"Klein","year":"1999","journal-title":"Transplantation"},{"issue":"8","key":"zoi230053r33","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1016\/j.transproceed.2009.09.026","article-title":"Biliary strictures after liver transplantation: risk factors and prevention by donor treatment with epoprostenol.","volume":"41","author":"Pirenne","year":"2009","journal-title":"Transplant Proc"},{"issue":"3","key":"zoi230053r34","first-page":"195","article-title":"Antithrombin III reduces renal ischemia-reperfusion injury in rats.","volume":"200","author":"Ozden","year":"2001","journal-title":"Res Exp Med (Berl)"},{"issue":"7","key":"zoi230053r35","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1161\/01.CIR.96.7.2302","article-title":"Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia\/reperfusion.","volume":"96","author":"Ostrovsky","year":"1997","journal-title":"Circulation"},{"issue":"1","key":"zoi230053r36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1182\/blood.V93.1.157","article-title":"Antithrombin reduces ischemia\/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin.","volume":"93","author":"Harada","year":"1999","journal-title":"Blood"},{"issue":"6","key":"zoi230053r37","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/tri.2006.19.issue-6","article-title":"Single-shot antithrombin in human pancreas-kidney transplantation: reduction of reperfusion pancreatitis and prevention of graft thrombosis.","volume":"19","author":"Fertmann","year":"2006","journal-title":"Transpl Int"},{"issue":"10","key":"zoi230053r38","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1111\/ajt.13815","article-title":"The Leuven immunomodulatory protocol promotes T-regulatory cells and substantially prolongs survival after first intestinal transplantation.","volume":"16","author":"Ceulemans","year":"2016","journal-title":"Am J Transplant"},{"issue":"6","key":"zoi230053r39","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1172\/JCI114656","article-title":"Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia\/reperfusion injury in the rat.","volume":"85","author":"Colletti","year":"1990","journal-title":"J Clin Invest"},{"issue":"1","key":"zoi230053r40","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1053\/gast.2002.30304","article-title":"Tumor necrosis factor a, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver.","volume":"122","author":"R\u00fcdiger","year":"2002","journal-title":"Gastroenterology"},{"issue":"5","key":"zoi230053r41","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/01.TP.0000115002.28575.E7","article-title":"Reduction of circulating redox-active iron by apotransferrin protects against renal ischemia-reperfusion injury.","volume":"77","author":"de Vries","year":"2004","journal-title":"Transplantation"},{"issue":"90","key":"zoi230053r42","first-page":"470","article-title":"Erythropoietin strongly protects the liver from ischemia-reperfusion injury in a pig model.","volume":"56","author":"Shimoda","year":"2009","journal-title":"Hepatogastroenterology"},{"issue":"38","key":"zoi230053r43","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.3748\/wjg.v16.i38.4838","article-title":"Erythropoietin ameliorates early ischemia-reperfusion injury following the Pringle maneuver.","volume":"16","author":"Kato","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"1","key":"zoi230053r44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1365-2249.2005.02958.x","article-title":"Inhibition of classical complement activation attenuates liver ischaemia and reperfusion injury in a rat model.","volume":"143","author":"Heijnen","year":"2006","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"zoi230053r45","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1046\/j.1365-2249.2001.01695.x","article-title":"Endothelial targeting with C1-inhibitor reduces complement activation in vitro and during ex vivo reperfusion of pig liver.","volume":"126","author":"Bergamaschini","year":"2001","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"zoi230053r46","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.jss.2013.09.009","article-title":"Human C1 inhibitor attenuates liver ischemia-reperfusion injury and promotes liver regeneration.","volume":"187","author":"Saidi","year":"2014","journal-title":"J Surg Res"},{"issue":"2","key":"zoi230053r47","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ejcts.2007.04.038","article-title":"Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind study.","volume":"32","author":"Fattouch","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"issue":"3","key":"zoi230053r48","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/(ISSN)1527-3350","article-title":"The model for end-stage liver disease (MELD).","volume":"45","author":"Kamath","year":"2007","journal-title":"Hepatology"},{"issue":"7703","key":"zoi230053r49","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41586-018-0047-9","article-title":"A randomized trial of normothermic preservation in liver transplantation.","volume":"557","author":"Nasralla","year":"2018","journal-title":"Nature"},{"issue":"5","key":"zoi230053r50","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.jhep.2014.07.021","article-title":"The beginning of an end point: peak AST in liver transplantation.","volume":"61","author":"Jochmans","year":"2014","journal-title":"J Hepatol"},{"issue":"4","key":"zoi230053r51","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/(ISSN)1527-6473","article-title":"The impact of postreperfusion syndrome on short-term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation.","volume":"14","author":"Hilmi","year":"2008","journal-title":"Liver Transpl"},{"issue":"6","key":"zoi230053r52","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1097\/00007890-199306000-00011","article-title":"Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury: modulating effects of FK506 and cyclosporine.","volume":"55","author":"Suzuki","year":"1993","journal-title":"Transplantation"},{"issue":"8","key":"zoi230053r53","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/(ISSN)1527-6473","article-title":"Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors.","volume":"16","author":"Olthoff","year":"2010","journal-title":"Liver Transpl"},{"issue":"2","key":"zoi230053r54","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications: five-year experience.","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"issue":"9","key":"zoi230053r55","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1016\/j.transproceed.2012.09.077","article-title":"Outcomes of liver transplantations using donations after circulatory death: a single-center experience.","volume":"44","author":"Meurisse","year":"2012","journal-title":"Transplant Proc"},{"issue":"4","key":"zoi230053r56","doi-asserted-by":"publisher","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure\u2014definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"issue":"10","key":"zoi230053r57","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1111\/ajt.13909","article-title":"2016 Comprehensive update of the Banff working group on liver allograft pathology: introduction of antibody-mediated rejection.","volume":"16","author":"Demetris","year":"2016","journal-title":"Am J Transplant"},{"issue":"4","key":"zoi230053r58","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/(ISSN)1527-6473a","article-title":"Banff schema for grading liver allograft rejection: utility in clinical practice.","volume":"5","author":"Ormonde","year":"1999","journal-title":"Liver Transpl Surg"},{"issue":"2","key":"zoi230053r59","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.soc.2017.11.001","article-title":"Systemic therapy for colon cancer.","volume":"27","author":"Wu","year":"2018","journal-title":"Surg Oncol Clin N Am"},{"key":"zoi230053r60","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2020.101681","article-title":"Immunosuppression in liver transplant.","volume":"46-47","author":"Di Maira","year":"2020","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"3","key":"zoi230053r61","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/S0016-5085(03)01048-5","article-title":"Protective strategies against ischemic injury of the liver.","volume":"125","author":"Selzner","year":"2003","journal-title":"Gastroenterology"},{"issue":"2","key":"zoi230053r62","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.transproceed.2007.01.022","article-title":"Pathomechanisms of ischemia-reperfusion injury as the basis for novel preventive strategies: is it time for the introduction of pleiotropic compounds?","volume":"39","author":"Menger","year":"2007","journal-title":"Transplant Proc"},{"issue":"4","key":"zoi230053r63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122214","article-title":"A systematic review of pharmacological treatment options used to reduce ischemia reperfusion injury in rat liver transplantation.","volume":"10","author":"Yamanaka","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"zoi230053r64","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1016\/j.jss.2011.09.057","article-title":"Excorporeal normothermic machine perfusion resuscitates pig DCD livers with extended warm ischemia.","volume":"173","author":"Xu","year":"2012","journal-title":"J Surg Res"},{"issue":"6","key":"zoi230053r65","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/MOT.0000000000000472","article-title":"Hypothermic liver perfusion.","volume":"22","author":"Schlegel","year":"2017","journal-title":"Curr Opin Organ Transplant"},{"issue":"2","key":"zoi230053r66","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/01.sla.0000110321.64275.95","article-title":"Glutathione protects the rat liver against reperfusion injury after prolonged warm ischemia.","volume":"239","author":"Schauer","year":"2004","journal-title":"Ann Surg"},{"issue":"6","key":"zoi230053r67","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3748\/wjg.v10.i6.864","article-title":"Intravenous administration of glutathione protects parenchymal and non-parenchymal liver cells against reperfusion injury following rat liver transplantation.","volume":"10","author":"Schauer","year":"2004","journal-title":"World J Gastroenterol"},{"issue":"2","key":"zoi230053r68","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/MOT.0b013e328337342b","article-title":"Machine perfusion of the liver: past, present and future.","volume":"15","author":"Monbaliu","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"issue":"5","key":"zoi230053r69","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.hbpd.2018.06.003","article-title":"Machine perfusion for liver transplantation: a concise review of clinical trials.","volume":"17","author":"Jia","year":"2018","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"5","key":"zoi230053r70","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1097\/SLA.0000000000003540","article-title":"Transplantation of high-risk donor livers after ex situ resuscitation and assessment using combined hypo- and normothermic machine perfusion: a prospective clinical trial.","volume":"270","author":"van Leeuwen","year":"2019","journal-title":"Ann Surg"},{"issue":"10","key":"zoi230053r71","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1097\/TP.0000000000002772","article-title":"Ex situ liver machine perfusion as an emerging graft protective strategy in clinical liver transplantation: the dawn of a new era.","volume":"103","author":"Nickkholgh","year":"2019","journal-title":"Transplantation"},{"issue":"5","key":"zoi230053r72","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1097\/SLA.0000000000001473","article-title":"First comparison of hypothermic oxygenated perfusion versus static cold storage of human donation after cardiac death liver transplants: an international-matched case analysis.","volume":"262","author":"Dutkowski","year":"2015","journal-title":"Ann Surg"},{"issue":"15","key":"zoi230053r73","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1056\/NEJMoa2031532","article-title":"Hypothermic machine perfusion in liver transplantation\u2014a randomized trial.","volume":"384","author":"van Rijn","year":"2021","journal-title":"N Engl J Med"},{"key":"zoi230053r1","unstructured":"Eurotransplant. Annual report 2019. June 11, 2020. Accessed November 9, 2021. https:\/\/www.eurotransplant.org\/annual-report\/annual-report-2019"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2801790\/meurisse_2023_oi_230053_1676492679.8064.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T18:37:59Z","timestamp":1701974279000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2801790"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.0819","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,28]]}}}